Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
The research provided includes analysis of the current state of the problem on the use of oral contraceptives and menopausal hormone therapy. These therapeutic options were evaluated in terms of their importance for the risk of breast cancer. The possibility of using these drugs in a cohort of high-...
Saved in:
Main Authors: | I. V. Vуsotskaya, V. P. Letyagin, I. K. Vorotnikov, V. U. Kirsanov, I. A. Gladilina, E. A. Kim |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/647 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Menopausal hormone therapy: oncological risks
by: I. V. Madyanov, et al.
Published: (2021-06-01) -
Risks of venous thromboembolic complications in related to combined oral contraceptives
by: K. A. Gabelova, et al.
Published: (2022-01-01) -
HORMONAL CONTRACEPTION AND MAGNESIUM DEFICIENCY: A SUBANALYSIS OF THE MAGYN STUDY
by: D. V. Blinov, et al.
Published: (2017-06-01) -
Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis
by: M. I. Yarmolinskaya, et al.
Published: (2021-01-01) -
Menopausal hormone therapy in certain diseases of therapeutic profile
by: I. V. Madyanov, et al.
Published: (2021-06-01)